Kimball Electronics Acquires Helvoet, Indianapolis Medical Hub Now Has a Technology Pipeline

Kimball Electronics closed its acquisition of Helvoet Polymer Technologies today, €90 million ($103 million), approximately 9x Helvoet's estimated 2026 adjusted EBITDA. Helvoet is a European contract development and manufacturing organization headquartered in Tilburg, Netherlands, specializing in micro-molding for microfluidics, diagnostic cartridges, and drug delivery components, with more than 70% of its $56 million in 2025 revenue from medical customers. The Indiana angle is specific: Kimball's Post Road facility in Indianapolis, ribbon-cut February 6, 2026, projected to add 345 jobs over six years, now has a named technology platform to fill it. CEO Richard Phillips called Indianapolis "a clear path for accelerating growth in the U.S." The company also rebrands to Kimball Solutions starting today, July 1, beginning with Jasper and Indianapolis. Phillips-Medisize and Jabil both completed medical CDMO acquisitions in early 2025. Kimball is a late entrant in a rapidly consolidating segment, but this acquisition is well-targeted. If you're in the Indiana medical supply chain, Kimball's cross-sell pipeline is now active, worth knowing where you sit relative to it before they set the agenda.